HomeAboutRankingsData Sources
© 2026 GeneE
🧬
GeneE
10 sources retrieved · Most recent: April 2026 · Index updated 14 days ago
ⓘGeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
GET4
guided entry of tail-anchored proteins factor 4
Chromosome 7 · 7p22.3
NCBI Gene: 51608Ensembl: ENSG00000239857.8HGNC: HGNC:21690UniProt: Q7L5D6
101PubMed Papers
21Diseases
0Drugs
0Pathogenic Variants
FUNCTIONAL ROLE
Transporter
CLINICAL
OMIM Disease Gene
DATA QUALITY
✓ Experimental GO Evidence✓ Swiss-Prot Reviewed
protein bindingprotein-folding chaperone bindingprotein carrier activityubiquitin-dependent protein catabolic processneurodegenerative diseasecongenital disorder of glycosylation, type IIyAbnormality of the skeletal systematrial fibrillation
✦AI Summary

GET4 (guided entry of tail-anchored proteins factor 4) functions as a core component of the BAG6/BAT3 cytosolic quality control complex that mediates post-translational protein targeting and quality control. As part of the transmembrane domain recognition (TRC) complex alongside BAG6 and UBL4A, GET4 facilitates delivery of tail-anchored proteins to the endoplasmic reticulum membrane 1. The complex coordinates with SGTA and ASNA1 to recognize hydrophobic transmembrane domains of newly synthesized proteins and load them onto the ATPase GET3 1. GET4 structurally primes GET3 for client loading by forming a composite lid over GET3's substrate-binding chamber 1. Beyond membrane protein targeting, GET4 participates in protein quality control by maintaining misfolded proteins in soluble states and directing them toward either ER delivery or proteasomal degradation 2. Nuclear BAG6-GET4-UBL4A complexes also mediate DNA damage signaling, with GET4 translocating to the nucleus upon DNA damage to facilitate cell death responses 3. Clinically, GET4 mutations cause congenital disorder of glycosylation 2Y, presenting with developmental delay, intellectual disability, and seizures due to disrupted tail-anchored protein targeting and retrograde ER-Golgi transport 2. GET4 is amplified and overexpressed in colorectal cancer, promoting tumor progression through enhanced BAG6 cytoplasmic localization and p53 acetylation 4. Additionally, GET4 emerges as an endoplasmic reticulum stress-related biomarker for type 1 diabetic cardiomyopathy 5.

Sources cited
1
GET4 coordinates with SGTA and GET3 in the pretargeting GET complex; forms composite lid over GET3 substrate-binding chamber to facilitate tail-anchored protein transfer and targeting
PMID: 34887561
2
GET4 is amplified driver gene in colorectal cancer; regulates BAG6 cytoplasmic localization; promotes tumor growth through BAG6-mediated p53 acetylation
PMID: 34704338
3
GET4 mutations cause congenital disorder of glycosylation 2Y with developmental delay, seizures, and intellectual disability; mutations disrupt tail-anchored protein targeting and retrograde transport
PMID: 32395830
4
Nuclear BAG6-GET4-UBL4A complex mediates DNA damage response; GET4 translocates to nucleus upon DNA damage and facilitates BRCA1 recruitment
PMID: 23723067
5
GET4 identified as endoplasmic reticulum stress-related biomarker for type 1 diabetic cardiomyopathy with diagnostic potential
PMID: 40171194
Disease Associationsⓘ21
neurodegenerative diseaseOpen Targets
0.54Moderate
congenital disorder of glycosylation, type IIyOpen Targets
0.43Moderate
Abnormality of the skeletal systemOpen Targets
0.37Weak
atrial fibrillationOpen Targets
0.24Weak
atrial flutterOpen Targets
0.20Weak
heart diseaseOpen Targets
0.08Suggestive
colorectal carcinomaOpen Targets
0.07Suggestive
neoplasmOpen Targets
0.07Suggestive
cardiac arrhythmiaOpen Targets
0.04Suggestive
hypertensionOpen Targets
0.02Suggestive
Alzheimer diseaseOpen Targets
0.02Suggestive
retinopathyOpen Targets
0.02Suggestive
infectious meningitisOpen Targets
0.02Suggestive
cancerOpen Targets
0.02Suggestive
colorectal cancerOpen Targets
0.01Suggestive
lymph node metastatic carcinomaOpen Targets
0.01Suggestive
cystOpen Targets
0.01Suggestive
nonpapillary renal cell carcinomaOpen Targets
0.01Suggestive
cholangiocarcinomaOpen Targets
0.00Suggestive
hepatocellular carcinomaOpen Targets
0.00Suggestive
Congenital disorder of glycosylation 2YUniProt
Pathogenic Variants
No pathogenic variants reported on ClinVar for this gene.
View on ClinVar ↗
Related Genes
RNF126Protein interaction96%SGTBProtein interaction90%UBL4AProtein interaction84%SEC61BProtein interaction82%AMFRProtein interaction80%RAD23AProtein interaction77%
Tissue Expression6 tissues
Liver
100%
Ovary
78%
Lung
68%
Brain
50%
Bone Marrow
48%
Heart
23%
Gene Interaction Network
Click a node to explore
GET4RNF126SGTBUBL4ASEC61BAMFRRAD23A
PROTEIN STRUCTURE
Preparing viewer…
PDB6AU8 · 1.80 Å · X-ray
View on RCSB ↗
Constraintⓘ
LOEUFⓘ
1.14LoF Tolerant
pLIⓘ
0.00Tolerant
Observed/Expected LoF0.76 [0.52–1.14]
RankingsWhere GET4 stands among ~20K protein-coding genes
  • #4,716of 20,598
    Most Researched101 · top quartile
  • #11,847of 17,882
    Most Constrained (LOEUF)1.14
Genes detectedGET4
Sources retrieved10 papers
Response time—
📄 Sources
10▼
1
Structural insights into metazoan pretargeting GET complexes.
PMID: 34887561
Nat Struct Mol Biol · 2021
1.00
2
GET4 is a novel driver gene in colorectal cancer that regulates the localization of BAG6, a nucleocytoplasmic shuttling protein.
PMID: 34704338
Cancer Sci · 2022
0.90
3
Circular SNX25 encoded radioresistance augmenter facilitates DNA damage repair in hepatocellular carcinoma by targeting BAG6-GET4 interaction.
PMID: 41120269
Cell Death Dis · 2025
0.80
4
Nuclear BAG6-UBL4A-GET4 complex mediates DNA damage signaling and cell death.
PMID: 23723067
J Biol Chem · 2013
0.70
5
Mutations in GET4 disrupt the transmembrane domain recognition complex pathway.
PMID: 32395830
J Inherit Metab Dis · 2020
0.60